Stay updated on PET-Directed Therapy With Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PET-Directed Therapy With Pembrolizumab Clinical Trial page.

Latest updates to the PET-Directed Therapy With Pembrolizumab Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.4 has been added and Revision: v3.3.3 has been removed, indicating a minor frontend/version update with no changes to study data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Locations sections for California, Georgia, Illinois, and New Jersey. Removed the HHS Vulnerability Disclosure entry and existing state location entries; revision updated to v3.3.3.SummaryDifference0.4%

- Check55 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no other content changes were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedPublications section now notes that PubMed entries are automatically filled and may not be about the study, and the revision version is updated to v3.3.1 (previously v3.2.0).SummaryDifference0.1%

- Check69 days agoChange DetectedThe banner notice about government funding lapses and NIH operating status has been removed. The study information on the page remains unchanged.SummaryDifference0.3%

- Check83 days agoChange DetectedNo significant changes detected between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to PET-Directed Therapy With Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PET-Directed Therapy With Pembrolizumab Clinical Trial page.